Choice of ABO Group for Blood Component Transfusion in ABO-Incompatible Solid Organ Transplantation: A Questionnaire Survey in Korea and Guideline Proposal
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
The number of ABO-incompatible solid organ transplantations (ABOi SOTs) has markedly increased worldwide since the early 2000s. We investigated the choice of ABO group for blood component transfusion in ABOi SOT. We conducted a survey by e-mailing a questionnaire to blood bank specialists at 77 major hospitals in Korea, among whom 34 responded to the survey. In major ABOi SOT, for red blood cells (RBCs), the recipient’s type (70.6%) was the most common choice, followed by group O (29.4%); for platelets, group AB (50.0%) was the most common choice, followed by the donor type (38.2%); for plasma, group AB (55.9%) was the most common choice, followed by the donor type (32.4%). In bidirectional ABOi SOT, for RBCs, the recipient’s type (55.9%) was the most common choice, followed by group O (44.1%); for platelets and plasma, group AB was the most common choice (94.1% and 97.1%, respectively). The policies for transfusion in ABOi SOT were diverse. We suggest a guideline on the choice of ABO group for transfusion in ABOi SOT to secure patient health and enable an efficient use of blood components.
Abstract
The number of ABO-incompatible solid organ transplantations (ABOi SOTs) has markedly increased worldwide since the early 2000s. We investigated the choice of ABO group for blood component transfusion in ABOi SOT. We conducted a survey by e-mailing a questionnaire to blood bank specialists at 77 major hospitals in Korea, among whom 34 responded to the survey. In major ABOi SOT, for red blood cells (RBCs), the recipient’s type (70.6%) was the most common choice, followed by group O (29.4%); for platelets, group AB (50.0%) was the most common choice, followed by the donor type (38.2%); for plasma, group AB (55.9%) was the most common choice, followed by the donor type (32.4%). In bidirectional ABOi SOT, for RBCs, the recipient’s type (55.9%) was the most common choice, followed by group O (44.1%); for platelets and plasma, group AB was the most common choice (94.1% and 97.1%, respectively). The policies for transfusion in ABOi SOT were diverse. We suggest a guideline on the choice of ABO group for transfusion in ABOi SOT to secure patient health and enable an efficient use of blood components.
참고문헌 (12)
- "2018. Annual data report" (2019)[URL]
- Kopko PM, "Transfusion support for ABO-incompatible progenitor cell transplantation", Transfus Med Hemother, 43, pp.13~18 (2016)
- Green L, "British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products : their handling and use in various patient groups in the absence of major bleeding", Br J Haematol, 181, pp.54~67 (2018)
- "Guidelines for transfusion and immunohaematology laboratory practice" (2020)[URL]
- Stotler BA, "Transfusion therapy: clinical principles and practice", pp.359~374 (2019), American Association of Blood Banks Press
- Das J, "Blood transfusion practices in liver transplantation", Indian J Anaesth, 59, pp.266~267 (2015)
- Refaai MA, "Is it time to reconsider the concepts of"universal donor"and"ABO compatible"transfusions?", Anesth Analg, 126, pp.2135~2138 (2018)
- Zaffuto BJ, "ABO-immune complex formation and impact on platelet function, red cell structural integrity and haemostasis: an in vitro model of ABO non-identical transfusion", Vox Sang, 110, pp.219~226 (2016)
- Shanwell A, "Post-transfusion mortality among recipients of ABO-compatible but non-identical plasma", Vox Sang, 96, pp.316~323 (2009)
- Kim HJ, "Outcome of ABO-incompatible kidney transplant depending on the ABO type of plasma transfused: comparative analysis between universal type AB plasma and donor type plasma", Korean J Transplant, 34(S1), pp.S189~ (2020)
- Kim H, "ABO-incompatible kidney transplantation can be successfully conducted by monitoring IgM isoagglutinin titers during desensitization", Transfusion, 60, pp.598~606 (2020)
- 김형석, "ABO 부적합 고형장기 이식에서의 수혈", 대한수혈학회지, 31(1), pp.70~72 (2020), 대한수혈학회[DOI]